Pollogen
Skin Nourishment and Oxygenation Technologies
Company Overview
Snapshot
Founded in June 2006 by Zion Azar, Pollogen operates with 51–200 employees. The company was acquired by Lumenis in November 2015, marking a significant milestone in its journey.
Business overview
Pollogen develops and manufactures non-invasive, minimally invasive, and non-surgical solutions for medical aesthetics professionals. The company's core technology addresses various skin concerns including acne scars, cellulite reduction, facial contouring, skin rejuvenation, and wrinkle reduction. Pollogen serves the health tech and life sciences sector, specifically targeting medical devices and cosmetic materials within the healthcare and consumer markets.
Strategic signal
In August 2019, Pollogen's TriPollar Stop home-use device received FDA clearance. This regulatory approval validates the safety and efficacy of Pollogen's technology for at-home use, signaling a potential for broader market penetration and increased consumer trust in its beauty device offerings.
Log in to access full profile ›Company Intelligence Q&A
- When was Pollogen acquired?
- Pollogen was acquired by Lumenis in November 2015.
- What was a key regulatory achievement for Pollogen's products?
- In August 2019, Pollogen's TriPollar Stop home-use device received FDA clearance.
- What new product did Pollogen expand its portfolio with in 2016?
- In November 2016, Pollogen, a Lumenis-owned company, expanded its portfolio with the Divine Pro, a holistic approach to repair the signs of aging.
- What was the focus of a clinical study by Pollogen in June 2016?
- In June 2016, a clinical comparative study showed that Hybrid Energy (VoluDerm HE) Micro-needle RF Technology by Pollogen is a safer and more tolerable treatment option for the aging neck with minimal pain and no downtime.
- What product did Pollogen highlight in May 2018?
- In May 2018, Pollogen highlighted Stop V as an ultimate solution for facial lifting, firming, and toning.